Filed: 11/14/2025ACC: 0001193125-25-281853
📋 What this filing means
FCPM III SERVICES B.V. filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $500.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$500.39M
Total AUM (reported)
39.63M
Total Shares
Allocation by class
ORDINARY SHARES$262.00M52.4%
COM$182.22M36.4%
COM NEW$27.37M5.5%
SPONSORED ADS$26.72M5.3%
W EXP 10/31/2028$2.07M0.4%
Portfolio Concentration
Top 3$396.90M79.3%
4–10$103.49M20.7%
Top 3 weight
79.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 39.63M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
39.63M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other9
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings9
Rows:
NEWAMSTERDAM PHARMA COMPANY
DFNDShares9.21M
TypeSH
Market value$262.00M
52.36%
Sole
0.00
Shared
9.21M
None
0.00
DYNE THERAPEUTICS INC
DFNDShares5.46M
TypeSH
Market value$69.11M
13.81%
Sole
0.00
Shared
5.46M
None
0.00
ENGENE HOLDINGS INC
DFNDShares9.63M
TypeSH
Market value$65.79M
13.15%
Sole
0.00
Shared
9.63M
None
0.00
ASTRIA THERAPEUTICS INC
DFNDShares4.11M
TypeSH
Market value$29.90M
5.98%
Sole
0.00
Shared
4.11M
None
0.00
BICYCLE THERAPEUTICS PLC
DFNDShares3.45M
TypeSH
Market value$26.72M
5.34%
Sole
0.00
Shared
3.45M
None
0.00
VOR BIOPHARMA INC
DFNDShares379.64K
TypeSH
Market value$18.50M
3.70%
Sole
0.00
Shared
379.64K
None
0.00
REPLIMUNE GROUP INC
DFNDShares4.16M
TypeSH
Market value$17.42M
3.48%
Sole
0.00
Shared
4.16M
None
0.00
RAPT THERAPEUTICS INC
DFNDShares344.24K
TypeSH
Market value$8.88M
1.77%
Sole
0.00
Shared
344.24K
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.88M
TypeSH
Market value$2.07M
0.41%
Sole
0.00
Shared
2.88M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 9.21M | SH | $262.00M 52.36% | 0.00 | 9.21M | 0.00 |
DYNE THERAPEUTICS INCDFND | COM | 5.46M | SH | $69.11M 13.81% | 0.00 | 5.46M | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 9.63M | SH | $65.79M 13.15% | 0.00 | 9.63M | 0.00 |
ASTRIA THERAPEUTICS INCDFND | COM | 4.11M | SH | $29.90M 5.98% | 0.00 | 4.11M | 0.00 |
BICYCLE THERAPEUTICS PLCDFND | SPONSORED ADS | 3.45M | SH | $26.72M 5.34% | 0.00 | 3.45M | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 379.64K | SH | $18.50M 3.70% | 0.00 | 379.64K | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 4.16M | SH | $17.42M 3.48% | 0.00 | 4.16M | 0.00 |
RAPT THERAPEUTICS INCDFND | COM NEW | 344.24K | SH | $8.88M 1.77% | 0.00 | 344.24K | 0.00 |
ENGENE HOLDINGS INCDFND | W EXP 10/31/2028 | 2.88M | SH | $2.07M 0.41% | 0.00 | 2.88M | 0.00 |